Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Ordinary shares, par value $0.0135 per share
Symbol
SLXN on Nasdaq
Shares outstanding
3,457,447
Price per share
$2.44
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
18,315
Total reported value
$35,165
% of total 13F portfolios
0%
Share change
+13,230
Value change
+$25,402
Number of holders
6
Price from insider filings
$2.44
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Moringa Sponsor, LP 15% $3,321,886 458,824 Moringa Partners Ltd 15 Sep 2025
INTRACOASTAL CAPITAL, LLC 9.4% -5.9% $695,500 +$171,690 325,000 +33% Mitchell P. Kopin 31 Dec 2025
Orca Capital AG 4.9% $802,137 109,432 Orca Capital AG 11 Sep 2025

As of 31 Dec 2025, 6 institutional investors reported holding 18,315 shares of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN). This represents 0.53% of the company’s total 3,457,447 outstanding shares.

Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 18,315 $35,165 +$25,402 $1.92 6
2025 Q3 5,085 $17,289 -$54,719 $3.40 4
2025 Q2 36,414 $29,495 +$29,495 $0.81 2